AU2002228660A1 - Use of amidoamines to treat or prevent acanthamoeba and fungal infections - Google Patents
Use of amidoamines to treat or prevent acanthamoeba and fungal infectionsInfo
- Publication number
- AU2002228660A1 AU2002228660A1 AU2002228660A AU2866002A AU2002228660A1 AU 2002228660 A1 AU2002228660 A1 AU 2002228660A1 AU 2002228660 A AU2002228660 A AU 2002228660A AU 2866002 A AU2866002 A AU 2866002A AU 2002228660 A1 AU2002228660 A1 AU 2002228660A1
- Authority
- AU
- Australia
- Prior art keywords
- acanthamoeba
- amidoamines
- treat
- prevent
- fungal infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/04—Amoebicides
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25757200P | 2000-12-20 | 2000-12-20 | |
US60/257,572 | 2000-12-20 | ||
PCT/US2001/044408 WO2002049633A2 (en) | 2000-12-20 | 2001-11-27 | Use of amidoamines to treat or prevent acanthamoeba and fungal infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002228660A1 true AU2002228660A1 (en) | 2002-07-01 |
Family
ID=22976832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002228660A Abandoned AU2002228660A1 (en) | 2000-12-20 | 2001-11-27 | Use of amidoamines to treat or prevent acanthamoeba and fungal infections |
Country Status (3)
Country | Link |
---|---|
US (1) | US7025958B2 (en) |
AU (1) | AU2002228660A1 (en) |
WO (1) | WO2002049633A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033208A1 (en) * | 2000-12-20 | 2004-02-19 | Cagle Gerald D. | Antifungal compositions containing an antibiotic and one or more amidoamines |
US20070264226A1 (en) * | 2006-05-10 | 2007-11-15 | Karagoezian Hampar L | Synergistically enhanced disinfecting solutions |
US8691899B2 (en) * | 2007-10-09 | 2014-04-08 | Ethicon, Inc. | Antimicrobial polymer compositions and the use thereof |
US8163684B2 (en) * | 2008-03-26 | 2012-04-24 | Abbott Medical Optics Inc. | Antimicrobials having polyquaternary ammoniums and alcohol-bearing amidoamines and methods for their use |
DE102008039254A1 (en) * | 2008-08-20 | 2010-02-25 | Megainpharm Gmbh | Medicament, useful e.g. for treating infectious- and purulent inflammatory diseases of e.g. eyes, comprises benzyl-dimethyl-(3-(myristoylamino)-propyl)-ammonium chloride, dimethyl-(3-(myristoylamino)-propyl)-amine oxide and solvent |
US20100120013A1 (en) * | 2008-11-07 | 2010-05-13 | Mb Research Laboratories, Inc. | Procedure for long term corneal culture |
WO2011100994A1 (en) * | 2010-02-19 | 2011-08-25 | Megainpharm Gmbh | Pharmaceutical comprising myramistin |
WO2013135571A1 (en) | 2012-03-14 | 2013-09-19 | Orphanidis Pharma Research Gmbh | Compositions with enhanced therapeutic efficacy against infective agents of the eye comprising miltefosine and polyhexamethylene biguanide |
WO2014058613A1 (en) | 2012-10-08 | 2014-04-17 | Bausch & Lomb Incorporated | Minimizing biological lipid deposits on contact lenses |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5393491A (en) * | 1993-09-22 | 1995-02-28 | Alcon Laboratories, Inc. | Use of amidoamines in ophthalmic compositions |
US5631005A (en) * | 1994-09-21 | 1997-05-20 | Alcon Laboratories, Inc. | Use of amidoamines in ophthalmic compositions |
US5573726A (en) * | 1993-09-22 | 1996-11-12 | Alcon Laboratories, Inc. | Use of amidoamines in ophthalmic compositions |
AR020661A1 (en) | 1998-09-30 | 2002-05-22 | Alcon Lab Inc | A PHARMACEUTICAL COMPOSITION TOPICA OFTALMICA, OTICA OR NASAL AND THE USE OF THE SAME FOR THE MANUFACTURE OF A MEDICINAL PRODUCT |
-
2001
- 2001-11-27 AU AU2002228660A patent/AU2002228660A1/en not_active Abandoned
- 2001-11-27 WO PCT/US2001/044408 patent/WO2002049633A2/en not_active Application Discontinuation
- 2001-11-27 US US10/415,836 patent/US7025958B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2002049633A3 (en) | 2003-05-01 |
WO2002049633A2 (en) | 2002-06-27 |
US7025958B2 (en) | 2006-04-11 |
US20040058924A1 (en) | 2004-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2000260550A1 (en) | Treatment of skin damage using polyenylphosphatidylcholine | |
AU2001285020A1 (en) | P97-active agent conjugates and their methods of use | |
AU2002225954A1 (en) | Dipeptidylpeptidases and methods of use | |
AU2001281140A1 (en) | Anti-plasmodium compositions and methods of use | |
AUPQ877300A0 (en) | Topical treatment of skin | |
AU2001241729A1 (en) | Protected forms of pharmacologically active agents and uses therefor | |
AU2001283285A1 (en) | Antimicrobial composition and methods of use in the treatment of disease | |
AU2002213346A1 (en) | Osteopontin-coated surfaces and methods of use | |
AU2002231206A1 (en) | Treatment of depression | |
AUPQ622600A0 (en) | Treatment and/or prevention of ocular pain | |
AU2002364964A1 (en) | Galliumcomplexes of 3-hydroxy-4-pyrones to treat mycobacterial infections | |
AU2002228660A1 (en) | Use of amidoamines to treat or prevent acanthamoeba and fungal infections | |
AU2001239846A1 (en) | Dsp with dual-mac processor and dual-mac coprocessor | |
AU2002219804A1 (en) | Water-in-oil insect repellent composition and method of application to the skin | |
AU2001233259A1 (en) | Use of desloratadine for treating allergic and inflammatory conditions | |
AU2001255696A1 (en) | Telomerase inhibitors and methods of their use | |
AU2001252627A1 (en) | Polybenzasol fiber and use of the same | |
AU2001268236A1 (en) | Use of aicar and related compounds | |
AU2001261496A1 (en) | Luxo-sigma54 interactions and methods of use | |
AU2001249692A1 (en) | Phospholipid scramblases and methods of use thereof | |
AU2001274022A1 (en) | Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments | |
AU2001284380A1 (en) | Therapeutic and cosmetic uses of heparanases | |
AU2002322810A1 (en) | Application of hair treatments and other formulations | |
AU2001267165A1 (en) | Prevention and treatment of mycoplasma-associated diseases | |
AU2001267177A1 (en) | Diagnosis and treatment of herpes infections |